The device is only part off the solution. The HMD device is currently the best there is. The Ai that sits behind the platform is now picking up preeclampsia which is a massive turn of events, HeraCARE is the game changer. HeraBEAT is really cool tech and competes with those other dopplers but the tech that is getting developed by HMD in tandem with JHC, Mednax, Sheba and Mayo far exceeds what those other dopplers offer.
there's the lead, and how you swing it.
Ann: Outstanding Results Achieved in Second JHC Clinical Trial, page-50
Add HMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.76M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 432216 | 2 |
View Market Depth
| Last trade - 12.22pm 02/08/2024 (20 minute delay) ? |
| HMD (ASX) Chart |
Day chart unavailable